Menu

Dog Disease Threatens Tigers

Wildlife veterinarians plan to track the canine distemper virus in Indonesia.

Jun 11, 2013
Kate Yandell

FLICKR, BRIAN MCKAYThe canine distemper virus may be infecting the Sumatran tiger, a critically endangered species living in Indonesia, according to BBC News. The virus, which devastated lions in the Serengeti in the 1990s, has become a major threat to wildlife.

“If you wind the clock back about 30 or 40 years, it was a dog disease—it was a canine virus and only affected dogs," John Lewis, director of Wildlife Vets International, told the BBC. "But in the intervening years, the virus has evolved and has changed its pattern of animals it can infect to include marine mammals (such as seals) and big cats."

Researchers believe that dogs must serve as a reservoir for the virus, and that big cats come into contact with the virus through contact with domestic dogs that have not been inoculated against it.

The virus has previously killed Siberian tigers in Russia. Now Lewis suspects it is infecting tigers on the Indonesian island of Sumatra. Symptoms of infection include respiratory problems and behavioral changes, including loss of fear for humans.

When Lewis visited Sumatra recently, he talked to local veterinarians who had heard reports of tigers coming into villages and behaving oddly, the BBC said. Lewis considers this a worrisome sign. When he returns to Indonesia in September he’ll start a program to track distemper in Sumatran tiger populations, an effort he hopes will serve as a model for surveillance programs in other tigers subspecies’ ranges.

“A tiger disease surveillance programme has never been tackled,” Lewis said in a Wildlife Vets International statement. “If we get it right, it could help us forestall a major problem, which is the last thing tigers need in their precarious state.”

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas, Inc., an emerging diagnostic company, launched a portfolio of products that can improve the accuracy of current diagnostic test results by helping laboratory professionals detect and manage biotin interference in patient samples with VeraTest Biotin and VeraPrep Biotin.
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
Scientists presented more than 30 abstracts featuring Bio-Rad’s Droplet Digital PCR (ddPCR) technology at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31–June 4.
BellBrook Labs Receives NIH Grant for the Discovery of cGAS Inhibitors to Treat Autoimmune Diseases
BellBrook Labs Receives NIH Grant for the Discovery of cGAS Inhibitors to Treat Autoimmune Diseases
The National Institute Of Allergy And Infectious Disease recently awarded BellBrook Labs a $300,000 Small Business Innovative Research (SBIR) grant to develop novel inhibitors for the target cyclic GAMP Synthase (cGAS). The grant will be used to accelerate the discovery of new treatments for autoimmune diseases by targeting the cGAS-STING pathway.